Owner Uses AI to Design Dog Cancer Vaccine
Get the Tech newsletter
Daily tech — startups, AI labs, chips, the launches that shape the next decade. Free.
- Paul Conyngham used ChatGPT to brainstorm cancer treatment ideas for his dog Rosie, leading him to immunotherapy and experts at the University of New South Wales.
- ChatGPT helped Conyngham parse medical literature and, together with AlphaFold, interpret the genetic profiling of Rosie's tumor.
- Pall Thordarson (UNSW professor) collaborated with Conyngham to develop a personalized mRNA vaccine targeting Rosie's tumor mutations, described as possibly the first such canine treatment.
- Rosie received her first vaccine injection in December, after which her tumors shrank and she showed improved activity, though one tumor remained unchanged and she is not cured.
- Checkpoint inhibitor immunotherapy was administered alongside the mRNA vaccine, making it unclear whether the vaccine alone caused the tumor shrinkage.
- David Ascher and other experts warned that AI tools acted as research assistants, not creators, and that the case is a proof of possibility rather than a reproducible template for pet owners.
Why it matters: The case shows pet owners can tap AI for research, but the actual therapeutic work still requires expert scientists, costly labs and specialized equipment, meaning only well‑funded teams can replicate such personalized vaccines. Overstating AI’s role could mislead owners into expecting quick cures.
